Shay Capital’s Organogenesis Holdings ORGO Stock Holding History

Shay Capital’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-150,000	Closed	-$498K	–	460
2023 Q2	$498K	Buy	+150,000	New	+$443K	0.07%	172

Other funds holding ORGO

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Shay Capital's ORGO Position: Q3 2023 in Review

Shay Capital sold out of Organogenesis Holdings (ORGO) in Q3 2023, closing a stake of 150,000 shares — an estimated $498K sold.

Shay Capital first reported a position in ORGO in Q2 2023 and held it in 1 quarter. The position peaked at $498K in Q2 2023. 104 funds tracked by Wall St. Rank hold ORGO as of Q3 2023.

Shay Capital reported no remaining Organogenesis Holdings position as of Q3 2023 after selling out during the quarter.
Shay Capital sold 150,000 Organogenesis Holdings shares in Q3 2023, an estimated $498K.
Shay Capital first reported a position in Organogenesis Holdings in Q2 2023 and held it in 1 quarter.
Shay Capital's Organogenesis Holdings position peaked at $498K in Q2 2023.
104 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q3 2023.

Based on Shay Capital's 13F filing for Q3 2023, filed 14 Nov 2023.